Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2161111 | Radiotherapy and Oncology | 2007 | 8 Pages |
Abstract
In case of PSAf after RRP, VUBx before SalvRT seems unnecessary for PSA ⩽ 0.9 ng/mL. For higher values, a positive VUBx seems to always justify a SalvRT, which may not be recommendable, given the nonnegligible risk of an already micrometastatic disease, if the biopsy results are negative.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marco Roscigno, Cesare Cozzarini, Vincenzo Scattoni, Roberto Bertini, Luigi Da Pozzo, Alessandra Pasta, Francesco Montorsi, Angelo Bolognesi, Claudio Fiorino, Renzo Colombo, Ferruccio Fazio, Patrizio Rigatti,